Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3847446

CS(=O)(=O)c1cccc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.49
CYP3A4 P08684 11/20 0.44
CLK4 Q9HAZ1 11/20 0.44
CYP1A2 P05177 10/20 0.44
MAPK1 P28482 7/20 0.44
HIF1A Q16665 7/20 0.44
ALDH1A1 P00352 7/20 0.44
LMNA P02545 6/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
USP2 O75604 8/20 0.44
MLYCD O95822 1/20 0.42
CYP2C19 P33261 4/20 0.41
CYP2D6 P10635 4/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 1/20 0.41
ENPP1 P22413 1/20 0.41
TSHR P16473 3/20 0.40
ALOX15 P16050 1/20 0.40
PDGFRB P09619 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4716295 0.93 CYP1A2 (0.50) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3851634 0.92 AKT1 (0.48) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3850108 0.92 AKT1 (0.51) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3847772 0.92 AKT1 (0.48) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3847451 0.92 AKT1 (0.49) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3851492 0.91 AKT1 (0.51) AKT1CYP3A4CLK4CYP1A2MAPK1
SCHEMBL13874385 0.90 ENPP1 (0.49) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3848184 0.90 AKT1 (0.48) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3854776 0.90 AKT1 (0.48) AKT1CYP3A4CLK4CYP1A2MAPK1
Trifluoroacetic Acid SCHEMBL3849063 0.89 AKT1 (0.47) AKT1CYP3A4CLK4CYP1A2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP claimed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US claimed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP claimed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed